Monday, May 20, 2024

GET OUR FREE E-NEWSLETTER

“You may choose to look the other way, but you can never say again that you did not know.”

— William Wilberforce

Search

America’s Own Overlooked Microcephaly Epidemic

Now that U.S. Centers for Disease Control and Prevention (CDC) officials have concluded that, without a doubt, the Zika virus is the cause of microcephaly,1 it appears they have created a permanent synonymous bond between the virus and the birth defect. When someone sees a baby with a smaller than normal head size, they will likely immediately think, “Oh, look at that poor…

How Conflicts of Interest Have Corrupted the CDC

Conflicts of interest have become more the rule than the occasional exception. Even the trusted US Centers for Disease Control and Prevention (CDC) receives heavy funding from industry. How this conflict of interest may have affected the organization’s decisions is the topic of an article in the British Medical Journal (BMJ), penned by the journal’s associate editor, Jeanne…

Nominee for FDA Commissioner Has Pharma Industry Ties

If confirmed by Congress, the next commissioner of the U.S. Food and Drug Administration (FDA) will be Robert M. Califf, MD. Dr. Califf is currently the FDA’s deputy commissioner for Medical Products and Tobacco—a position to which he was appointed on January 26, 2015, just two months prior to the end of former FDA commissioner Margaret Hamburg’s six-year term.

Does Pharma Pressure Sway FDA Drug Approvals?

pills and containers

For patients and physicians, the common belief is that all drugs undergo the same rigorous review, but the truth is, the Food and Drug Administration (FDA), which stands as the gatekeeper for the sanction of drug and device products, has flexible standards on what they approve and do not approve. Unknowingly to the public, the federal agency approves drugs based on…

Pharma-Government Conflicts of Interest Exposed

Conflicts of interest are rampant and easily made public in doctor-pharmaceutical relationships, however, they stay a little more hidden for industry and federal agencies. While it is inevitable that big pharma be present in public health agencies as individual leaders bounce from organization to organization—meanwhile maintaining past relationships, roles and…

Search in Site

To search in site, type your keyword and hit enter

Search